Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Gastro Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Gastro Other
    Some Antidepressants Associated With Gastrointestinal Bleeding - (DGNews)
    European Commission Approves Methylnaltrexone Bromide for Opioid-Induced Constipation in Advanced Illness - (DGNews)
    Device Blocking Stomach Nerve Signals Shows Promise in Obesity - (DGNews)
    Gastric Bypass Surgery Linked to Increased Risk of Kidney Stones - (DGNews)
    Weight Loss After Gastric, Laparoscopic Surgery Improves Health in Adults, Teens - (DGNews)

    News archive

     Recent webcasts/CME - Gastro Other
  • Chronic Constipation: An Update on Options and Issues for the Managed Care Pharmacist
  • Fresh Perspectives in Chronic Constipation and Other Functional Bowel Disorders

    Webcasts/CME archive

     Recent cases - Gastro Other
      Lethal Necrotizing Pancreatitis Complicating a "One Shot" Percutaneous Ethanol Injection into a Multifocal Hepatocellular Carcinoma: Case Report
      Coffee-Bean Sign
      Torsion of Vermiform Appendix with Fecalith: A Case Report
      Pancreatitis with an Unusual Fatal Complication Following Endoscopic Retrograde Cholangiopancreaticography: A Case Report
      Candida Esophageal Perforation and Esophagopleural Fistula: A Case Report

      Cases archive
        




      my personal edition > gastro other > news
      divider

        E-Mail this DGDispatch to a colleague

      DGDispatch


      Gallbladder Cancer Responds to Chemotherapy: Presented at ASCO-GI

      By Roberta Friedman, PhD

      SAN FRANCISCO, CA -- January 26, 2004 -- Chemotherapy can extend the life of patients with inoperable or metastasized cancer of the gallbladder, according to a study reported here January 24th at the First Annual Gastrointestinal Cancers Symposium, sponsored jointly by the American Society of Clinical Oncology and other societies.

      Study presenter José Reyes-Vidal, MD, Clinica Las Condes, Las Condes, Chile, said Chile has appreciable rates of gallbladder cancer, which is relatively rare elsewhere. It is the main cause of cancer mortality in Chilean women, Dr. Reyes-Vidal said, and "we expect it to increase in the next 10 years."

      Of 44 patients treated. 42 had at least a single course of chemotherapy, and the objective response rate was 48%. This included four patients who had a complete response.

      "Gallbladder cancer is responsive to chemotherapy," said Dr. Reyes-Vidal, "we can obtain a response in this very poor prognostic cancer, in almost 50% of our patients."

      Median survival was three or four times the historical rate of 73 days for untreated patients, he added. And, the patients had a "dramatic" improvement in quality of life, he said, "that was my clinical impression."

      The regimen was 1200 mg/m2 of gemcitabine and 35 mg/m2 of cisplatin on days 1 and 8, every 21 days for a total of six courses.

      Factors that put people in Chile at risk of gall bladder cancer include obesity and gallstones, especially stones bigger than 3 cm in diameter, Dr. Reyes-Vidal said. "We are studying what happens if we take these patients and perform cholecystectomy."

      Researchers in Chile are also considering if screening for gallstones would be cost effective, he said.


      [Study title: Gemcitabine (Gem) and cisplatin (CIS) in the treatment of patients (pts) with unresectable or metastatic gallbladder cancer. Results of the phase II GOCCHI study 2000-13. Abstract OP87]



      E-Mail this DGDispatch to a colleague   To print, use this version






      All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send